Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -1.84 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
Where are those poor bears saying, ( kids mimicking voice) I am still in the green, shorting since $165. I will see you at $90 or 80.
In reality they shorted it at $103 and I told them by the end of this week they will be losing 75% of their money. And by ER their retirement and house will be gone too.
There is not a single reason to be a bear in $MRNA, unless you do not want your money -
27 days till ER!!! The expected EPS is (-0.21) vs last year reported EPS was (-0.37). You all know what will happen when $MRNA reports comes out. Just so some people get an idea what the 300M doses sold to the US alone means to $MRNA ER. That is $4.5B, I am not going to add the sales of other countries, you can go and do that work. But for now you can easily calculate the EPS based on the US sales.
$4.5B divided by 395.71M outstanding shares. That is $11.3719 what!!!!! so the expected EPS of $-0.21 is what the bears were dreaming of.
Now you see how big $MRNA is going to be. If my math is correct, that will be over 5000% year over year!!! -
If JNJ even make a vaccine. That will do nothing to their stock because they still trying to make money to pay the baby powder enormous lawsuit. Based on that. No many trust JNJ to make anything good anymore. Yes, people do not trust them.
$MRNA is what the new generations will know for now on. They are just starting, and starting really good. They essentially have no Debts like JNJ does. -
27 days till ER!!! The expected EPS is (-0.21) vs last year reported EPS was (-0.37). You all know what will happen when $MRNA reports comes out. Just so some people get an idea what the 300M doses sold to the US alone means to $MRNA ER. That is $4.5B, I am not going to add the sales to other countries, you can go and do that work. But for now you can easily calculate the EPS. $4.5B divided by 395.71M shares. That is $11.3719, so the expected EPS of $-0.21 is what the bears were dreaming of. Now you see how big $MRNA is going to be.
-
Soon the bears here will be like the bears at AMC today. Their retirements are gone and their houses.
-
No worries, $MRNA already sold 300M doses to the US alone. The ER will be huge year over year.
-
When it hits the $200-$210. Then you can call it high. But this will continue till COVID is under control, which we all know. It will take awhile..
-
I can’t believe there are still a few bears here. I thought they would be at the bar crying about their loses to the bartender. saying. I just wanted to make a little money and now my retirement is gone!!! Whahahaha why, why, why me?
-
JNJ.
Never argue on price of fish that currently are in the ocean. Ha?
Yeaaa. This is something you not learn in Harvard university.Ha?
-
How are the poor bears doing in this lovely $MRNA day? Still waiting on JNJ ?
-
JNJ is still trying to make money to pay their huge debt from the baby powder lawsuits. That is if their vaccine actually passes the 3rd phase.
$MRNA on the other hand is increasing capacity to keep up with the demand of the vaccine that it is actually selling. And now with all the extra cash they have. They will expand, and the pipeline for other treatments is looking great. -
For those promoting JNJ here and saying they rather wait for it. Go wait and post your thoughts in the JNJ stock. That way you can promote it there for JNJ investor to help the stock. It doesn’t help you or JNJ stock posting here.
$MRNA is doing just fine here since last year. And we didn’t have to wait much. -
For the people asking why $MRNA price is this high and want to compare to $PFE. Here are some numbers to think about.
PFE : total cash = $10.52B and total debt= $63.15B
MRNA : total cash = $3.28B and total debt= $212.29M yes, Millions NOT Billions.
Yes, companies have big debts. That money is used to make more money. You all are very familiar with that practice, but also you all know that it is much better to make more money with your own money, just like $MRNA is about to do with it’s new found fortune. -
Proud bag holder .... AVG of $22 w/ 200 shares ... I don’t listen to stupid people jajajajaja . Waiting for the big moment to sell .
-
Where are those 3 bears that keep dreaming of the $90 and $80 price?
They shorted it at the $105. Soon they will see 50% of their money gone. By all time high, 75% of their money would be gone, that might be this Friday. At earning report they will lose their retirement. Sorry bears, but you have been reading my posts here and didn’t want to listen. There is not a single reason to short $MRNA. They are saving the world, they sold out, now the government will pay all their expenses to even make more vaccines.
About the CEO selling some of his stocks, that is great. That means there are plenty of buyers and they are buying because $MRNA if the future of medicine. Go check out their pipeline that they have been working on. I am so glad $MRNA is making all this money, because they will reinvest it to accelerate the work on their other medicine they are working on. -
Hey guys
We are +2% in .
Just FYI.
-
Nothing stopping $MRNA to the $155, buy buy buy. After that we will have a small pause around last ATH to easily go to the $210. Remember that the USA wants to move at warp speed against COVID, well guess what, $MRNA price will be also doing that. Right now we are about to repeat what happened exactly 2 months ago, just open the 6 months chart.
-
By Deena Beasley
Jan 25 (Reuters) - Drugmaker Merck & Co on Monday said it will end development of its two COVID-19 vaccines, and will focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March.
-
Do not mess with this monster.
MRNA. To 250 EOY
-
People sell bcz they think next week
JNJ will bit MRNA with 95% efficacy !Well. My grandma told me : If you are fishermen never save money’s from the fish that right now in the ocean.
Or. The bird 🦢 ... bush ...staff
Go MRNA !!!!
-
(MRNA) Investment Analysis
news.google.com • -
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
news.google.com • -
Stocks on Sale, Novavax, Moderna, and More
news.google.com • -
Stocks on Sale, Novavax, Moderna, and More
news.google.com •